Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)

CNY 15.62

(0.64%)

Operating Income Summary of Sichuan Huiyu Pharmaceutical Co., Ltd.

  • Sichuan Huiyu Pharmaceutical Co., Ltd.'s latest annual operating income in 2023 was 124.36 Million CNY , down -97.72% from previous year.
  • Sichuan Huiyu Pharmaceutical Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 32.96 Million CNY , up 62.59% from previous quarter.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported an annual operating income of 235.44 Million CNY in 2022, down -50.82% from previous year.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported an annual operating income of 478.75 Million CNY in 2021, up 20.29% from previous year.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported a quarterly operating income of 20.27 Million CNY for 2024 Q1, up 3.0% from previous quarter.
  • Sichuan Huiyu Pharmaceutical Co., Ltd. reported a quarterly operating income of 179.38 Million CNY for 2024 Q3, up 444.25% from previous quarter.

Annual Operating Income Chart of Sichuan Huiyu Pharmaceutical Co., Ltd. (2023 - 2017)

Historical Annual Operating Income of Sichuan Huiyu Pharmaceutical Co., Ltd. (2023 - 2017)

Year Operating Income Operating Income Growth
2023 124.36 Million CNY -97.72%
2022 235.44 Million CNY -50.82%
2021 478.75 Million CNY 20.29%
2020 398 Million CNY 99.14%
2019 199.85 Million CNY 383.19%
2018 -70.57 Million CNY 16.26%
2017 -84.27 Million CNY 0.0%

Peer Operating Income Comparison of Sichuan Huiyu Pharmaceutical Co., Ltd.

Name Operating Income Operating Income Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 96.183%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY 45.051%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 97.571%
Harbin Pharmaceutical Group Co., Ltd. 659.62 Million CNY 81.146%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 89.871%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY 67.285%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 88.663%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY 183.48%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 96.392%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY 7437.519%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 96.453%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY -464.319%
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY 69.122%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY 50.076%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 90.873%
Shanghai Haoyuan Chemexpress Co., Ltd. 128.32 Million CNY 3.086%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY -563.37%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 89.422%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 89.398%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY 69.802%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY -2.128%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY 26.586%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY 81.05%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY -28.12%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY 14.531%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY 77.941%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY 191.964%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 95.968%
KPC Pharmaceuticals, Inc. 568.49 Million CNY 78.123%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY -28.096%
North China Pharmaceutical Company Ltd. 540.51 Million CNY 76.991%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 91.791%
Tibet Weixinkang Medicine Co., Ltd. 174.96 Million CNY 28.917%
China National Medicines Corporation Ltd. 2.94 Billion CNY 95.776%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY -39.048%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY 73.72%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY -53.35%
Dali Pharmaceuticalco.,Ltd -17.03 Million CNY 830.065%
Changchun BCHT Biotechnology Co. 559.29 Million CNY 77.763%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY 372.284%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY 586.285%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 86.09%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY 76.824%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY 79.012%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY 47.549%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 96.24%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY 78.328%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY 36.691%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY 6.268%
Guobang Pharma Ltd. 702.26 Million CNY 82.29%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY 301.235%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY -43.503%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY 71.476%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY 10.484%
Henan Taloph Pharmaceutical Stock Co.,Ltd 44.16 Million CNY -181.59%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY 73.077%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY 137.471%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY 35.946%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 88.502%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY 36.369%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 86.167%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY 28.487%
CanSino Biologics Inc. -1.93 Billion CNY 106.422%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY 28.84%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY 55.129%